Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
about
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidasesResistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsNeuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenPandemic influenza threat and preparednessAntiviral drugs for viruses other than human immunodeficiency virusStructure of influenza hemagglutinin in complex with an inhibitor of membrane fusionSafety and efficacy of peramivir for influenza treatmentStructural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B VirusesInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceAntiviral resistance and the control of pandemic influenzaA randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combinationPopulation-wide emergence of antiviral resistance during pandemic influenzaEfficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza virusesOseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferretsInfluenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case studyEfficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesChemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant ratsInfectious respiratory disease outbreaks and pregnancy: occupational health and safety concerns of Canadian nurses.Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.Preparing for pandemic influenza: should hospitals stockpile oseltamivir?Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.Antiviral management of seasonal and pandemic influenza.Avian influenza virus (H5N1): a threat to human health.Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.Continuing challenges in influenza.Antiviral treatment for the control of pandemic influenza: some logistical constraintsGlycosidase inhibitors: a patent review (2008-2013).Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.The role of oseltamivir in the treatment and prevention of influenza in children.Antiviral medication use in a cohort of pregnant women during the 2009-2010 influenza pandemic.Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) VirusesModeling the effects of drug resistant influenza virus in a pandemic.Meeting report: risk assessment of tamiflu use under pandemic conditions.Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.Antivirals for the treatment and prevention of epidemic and pandemic influenzaZanamivir-resistant influenza viruses with a novel neuraminidase mutationSeasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.
P2860
Q21142689-D276015A-8EE3-499A-B9AF-BF9011D07C20Q22305941-72CC6F9C-2012-4E4F-B176-EE7C2BEEF30BQ24203905-F99157B3-C9B4-433A-97AA-B2C4BA7F7194Q24628578-122C5696-D023-44E3-B51E-7193577B7EEAQ24635330-41DE3E6F-A063-4A12-AEF6-04C9574ADD73Q24656213-EEA3E536-0863-40A8-A085-6A8902DF0C02Q27027408-4F7D3F00-25F5-41C7-938E-6FF193914BB6Q27663966-BADA661A-1363-4FAC-9CCB-78289EBFEA87Q28282405-D1459D2F-4ED8-4B34-A418-6A81C0467284Q28469119-990FD456-E28B-4816-AE06-C691385A816BQ28471710-C5B9D5F9-80A3-42BE-9F04-F921874DCDEAQ28472381-9D262B56-0C23-4D06-B41F-AE2D1B397875Q28473051-E4C676A5-C4C9-4535-A609-4A4E596556BDQ28474960-CE056A2C-85F6-4EE1-87BD-4EE5122B6BFFQ28476585-FD318033-AD51-46F7-8753-D0062DDDBC8EQ28479036-C5ADA199-320E-4F8F-A011-301511BD2DC0Q28484222-64A5A984-11DC-4166-9C31-338F2B14539FQ30226417-AAE7243D-BE49-4ECF-A281-A60AA5314960Q30228322-409CBBB2-F658-48FA-B6E4-52F7A893DBE2Q30352052-B562152E-FFF0-4E4A-A27E-9FC660CBDFAFQ30356532-6FA34F6D-B77A-4692-B17C-7D78F5F27B45Q30357189-70896E9A-698B-4BC7-8846-E55ECDBDCB0EQ30358735-BFBE76BB-918B-4F2C-ADA8-10EBF372C8CAQ30361041-D6A07F29-B593-47F6-9E55-3EBF533B9CEBQ30361125-2957B643-AFE2-454C-B200-54583AA65BE6Q30362700-F045A7B7-E3BA-40E6-AD2A-EE861551A5F3Q30363190-6083CE5C-77A4-4B41-BFDD-67803A9C6933Q30363640-98F29D88-4F22-424F-AA97-70D2556F014DQ30363930-30648CFA-7244-48D1-9825-16B75BCBE38FQ30364619-CF6770AF-5C75-48E9-80B7-0382BA11ECA0Q30364977-002E68C8-55B2-4E1C-BAF8-090A1BAB558EQ30368782-19E6DABD-87E3-4A66-9137-9AB61DBD7697Q30372421-346BCFDF-B045-4232-8B79-6BBBF96CB17FQ30373057-8E5FF40D-FF35-4F92-B412-1E6A394BC72AQ30373734-0336ACE5-46C5-4F06-9D9B-61558AA8F8F6Q30374227-E7946395-B9AD-4C74-9423-971DF19AAE1BQ30376004-783A3766-C52F-49B6-A5B4-C4E237B6BF7DQ30377241-9D58C327-44CB-4865-922E-AE0B52C37D97Q30379353-8934A682-8D47-4F1E-9201-E1940D09C8F7Q30382632-3FE4FBDF-FA73-48CB-87B0-C8AEE18F0271
P2860
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
@ast
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
@en
type
label
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
@ast
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
@en
prefLabel
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
@ast
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
@en
P2093
P356
P1476
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
@en
P2093
James Smith
Penelope Ward
Regina Dutkowski
P304
P356
10.1093/JAC/DKI018
P407
P478
55 Suppl 1
P577
2005-02-01T00:00:00Z